Insight Brief
April 19, 2017

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Successful seasonal flu vaccine development depends on protecting the world's population against the top 3-4 strains that are expected to be in circulation for the flu season. Keeping track of the flu requires a combination of precision tools, carefully managed processes and high caliber scientific and regulatory expertise.

Download our insight brief and learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials. Q2 Solutions' experts understand the critical success factors to support your needs for the development of safe and effective vaccines in time to protect people from seasonal flu.

Wayne Hogrefe, Ph.D., D (ABMLI), Vice President, Q2 Solutions
Sorika van Niekerk MSc, UP, SA, Senior Director, Q2 Solutions
Ayaskant Pany, M.D., Director, Q2 Solutions

Related Services:
Q2 Solutions Anti-infective and Vaccine Development Services

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Read More